Latest News and Press Releases
Want to stay updated on the latest news?
-
VANCOUVER, British Columbia, July 28, 2022 (GLOBE NEWSWIRE) -- Highlights Strong lithium grades over wide intervals returned from first two drill holes completed during the summer phase...
-
ST. LOUIS, July 27, 2022 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.1 billion for the three months ended June 30, 2022, compared with $1.2 billion a year...
-
Open Label Extension Study Will Evaluate Baxdrostat for Up to 52 Weeks Topline Data for Phase 2 HALO Trial Expected in 2H 2022 Topline Data for Phase 2 BrigHtn Trial Expected in August 2022 ...
-
OTTAWA, July 19, 2022 (GLOBE NEWSWIRE) -- Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV:CGP; OTC:CTNXF; FWB:GWN1) is pleased to provide an update on its Bramaderos gold...
-
THE WOODLANDS, TX, July 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – SPYR, INC. (OTCQB: SPYR), a diversified technology company developing products leveraging the Internet of Things (IoT) for...
-
OTTAWA, June 28, 2022 (GLOBE NEWSWIRE) -- Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV:CGP) (Frankfurt:GWN) (Berlin:GWN) (OTC:CTNXF) is pleased to announce the following...
-
VANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) -- Highlights Best lithium intercept to date returned from final suite of drill holes reported from the winter phase of the 2022 drill...
-
June 14, 2022 17:08 ET | Source: Healthcare Realty Trust Incorporated; Healthcare Trust of America, Inc.
SCOTTSDALE, Ariz., June 14, 2022 (GLOBE NEWSWIRE) -- Healthcare Trust of America, Inc. (“HTA”, NYSE: HTA) announced today that its operating partnership, Healthcare Trust of America Holdings, LP...
-
Highlights Continued strong lithium grades returned from drill holes testing the main pegmatite body beneath the shallow lake connecting the CV5 and CV1 pegmatite outcrops 1.17% Li2O and 156 ppm...
-
Immunovant plans to initiate two placebo-controlled Phase 3 clinical trials of batoclimab in thyroid eye disease (TED) in the second half of calendar year 2022 with top-line data expected for both in...